Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Change in Receivables (2016 - 2025)

Haemonetics (HAE) has 17 years of Change in Receivables data on record, last reported at -$11.1 million in Q4 2025.

  • For Q4 2025, Change in Receivables fell 724.39% year-over-year to -$11.1 million; the TTM value through Dec 2025 reached -$17.7 million, down 10245.61%, while the annual FY2025 figure was -$7.0 million, 128.75% down from the prior year.
  • Change in Receivables reached -$11.1 million in Q4 2025 per HAE's latest filing, down from $7.3 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $30.6 million in Q4 2023 and bottomed at -$25.5 million in Q2 2021.
  • Average Change in Receivables over 5 years is $2.2 million, with a median of $911000.0 recorded in 2023.
  • The widest YoY moves for Change in Receivables: up 618.57% in 2024, down 7060.78% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $9.2 million in 2021, then decreased by 20.63% to $7.3 million in 2022, then surged by 317.63% to $30.6 million in 2023, then crashed by 94.21% to $1.8 million in 2024, then tumbled by 724.39% to -$11.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$11.1 million in Q4 2025, $7.3 million in Q3 2025, and -$3.6 million in Q2 2025.